BC Platforms acquires Medexprim
BC Platforms acquires Medexprim, expanding our ability to deliver secure access to Real-World clinical and imaging Data for global biopharma across Europe.
Check out the latest updates
-
Read more
-
BC Platforms partners with NTT to accelerate data-driven medicine in Japan
Read moreBC Platforms and NTT join forces to integrate and harmonize Japanese healthcare data, supporting data-driven medicine and nationwide personalized care.
-
BC Platforms acquires 4Pharma
Read moreBC Platforms strengthens its global offering with the acquisition of 4Pharma, combining CRO expertise with advanced Real-World Data technology.
-
BC Platforms selected as partner in key Singapore population health study
Read moreBC Platforms powers data analysis for the HELIOS study in Singapore, advancing the nation’s precision medicine programme and enabling insights across major chronic diseases.
-
Partnership of BC Platforms, Euformatics, and Oncompass Medicine, selected to deliver standardized oncology NGS workflows for seven major European hospitals
Read moreBC Platforms and partners win phase 2 of the Instand-NGS4P project, continuing work to deliver standardized NGS-based oncology workflows across leading European hospitals.
-
BC Platforms partners with EU-funded, AI-Driven, cancer data initiative
Read moreBC Platforms partners with HUS on ONCOVALUE, a Horizon Europe project creating an AI framework to turn clinical data into Real-World Evidence for cancer treatment decisions.
-
BC Platforms announces USD 20 Million growth financing led by Jolt Capital
Read moreBC Platforms secures CHF 20 million in new financing led by Jolt Capital to accelerate innovation and scale our healthcare data and analytics capabilities worldwide.
Get in touch
For press and media inquiries, contact our communications team at media@bcplatforms.com.
For partnerships, business opportunities, and all other inquiries, please fill out this form